3D BIOANALYTIX, INC.

3D BIOANALYTIX, INC. specializes in advanced bioanalytical research and diagnostic technology development, leveraging cutting-edge microfluidics, biosensor integration, and high-throughput data analytics to support biomedical innovation. The company focuses on translating laboratory-scale bioassays into scalable, field-deployable platforms for rapid pathogen detection, biomarker identification, and molecular diagnostics. Their technical expertise includes point-of-care device design, lab-on-a-chip systems, multiplexed immunoassays, and AI-driven signal processing for low-sample-volume analyses. A key differentiator is their proprietary integration of nanomaterial-based sensing elements with portable instrumentation, enabling high-sensitivity detection in resource-limited environments. The firm is certified as a Women-Owned Small Business and a Woman-Owned Business, reflecting its commitment to diversity in federal contracting and innovation-driven leadership. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal collaboration can be inferred. Similarly, without contract data, primary NAICS categories cannot be determined, though the company’s technical profile suggests alignment with biomedical R&D, clinical diagnostics, and advanced life sciences instrumentation sectors. The company is headquartered in San Diego, CA, a major hub for biotech and defense-related life sciences, positioning it within a dense ecosystem of research institutions and federal partners. As a small business with women-owned certification, 3D BIOANALYTIX, INC. is strategically positioned to compete for set-aside contracts in federal health, defense, and public health preparedness programs. Their operational model emphasizes agility, intellectual property development, and translational research—bridging academic innovation with mission-critical government requirements.